LAS VEGAS, Dec. 14, 2021 (GLOBE NEWSWIRE) — Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based products for heart and brain health, has introduced a line of products for Whitney Johns, the company’s first major influencer under its recently launched brand influencer program.

An accomplished fitness athlete, model, popular personal trainer, entrepreneur, and nutrition advocate, Whitney has attracted more than a million followers across Instagram, Facebook, TikTok, Twitter, and YouTube.
“These new amazing products represent another important way that I can help my many followers who are seeking natural ways to enhance their fitness performance, health and wellness,” said Whitney.
The new Whitney Johns line of brain, physical performance and women’s hormone health products are based upon the Healthy Extracts’ all-natural Citrus Bergamot SuperFruit™ and Ultimate Brain Nutrients™ formulations. They are vegan friendly, non-GMO, gluten-free, organic, made in a certified U.S. facility, and supported by extensive published clinical research.
“This is the first launch of a new product line under our brand influencer program and was designed especially for Whitney’s health-conscious audience,” stated Healthy Extracts president, Duke Pitts. “Backed by Whitney’s tremendous personal endorsement and brand marketing strength, we see this new line dramatically elevating our social engagement, strengthening our brand identity, and especially accelerating revenue growth at minimal cost.”
“We believe major brand influencers like Whitney will help our formulations reach millions of consumers, as well as gaining prime placements on the shelves of major retailers nationwide,” Pitts added.
Whitney’s personalized diet and fitness program, Find Your Fit with Whit, helps individuals achieve their personal fitness and nutritional goals.
Pre-orders for Whitney Johns line of brain, physical performance and women’s hormone health products will begin later this month, with initial shipments commencing in January.
The new Whitney Johns product line includes:
BRAIN ACTIVATE™ is specially formulated to support focus, memory, cognition, mood and brain health. Whether as a scoop added to water or coffee, or mixed in a smoothie, or enjoyed in the new gel format, BRAIN ACTIVATE’s powerful mental activation benefits can last up to eight hours or more. These benefits are a result of the company’s KETONOMICS® proprietary formulations clinically shown to quickly generate strong and sustained ketone levels in the brain.
EEG brain scan images showed a 46% increase in brain activation after consuming the company’s active ingredients. See the complete study here.
Naturally derived, with zero sugar and caffeine, this patented proprietary formulation includes a blend of pure C8 medium chain triglycerides (MCTs), naturally-sourced spearmint and marigold clinically shown to support mental focus during the day without disrupting sleep at night; a protective antioxidant found naturally in the body that promotes optimum brain function, better mood and sleep habits; and a unique natural marigold extract scientifically shown to block blue light and replenish lutein, a substance critical to eye health. The uniquely concentrated formulation provides the perfect “brain food” for sustained mental energy and focus.
Healthy Extracts has two patents issued and multiple pending applications on its proprietary formulations. They have been in development for more than 20 years and are supported by more than 100 clinical studies.
ACTIVE™ is suitable for anyone looking to improve their physical performance, recovery, endurance, and oxygen consumption (VO2 max), as well as weight management, by providing a daily dosage of 1,200 milligrams of the world's strongest bergamot extract, Citrus Bergamot SuperFruit™.

The superfruit has been shown by more than 17 clinical studies to possess powerful health benefits for the heart and metabolism, and it is offered exclusively in North America by Healthy Extracts.
WOMEN’S HORMONE SUPPORT™ supports hormone balance, energy, mood, libido, and aids in metabolizing fat, and is a strong anti-inflammatory. It contains highly concentrated citrus bergamot tablets with a daily dosage of 1,000 milligrams.
ACTIVE and WOMEN’S HORMONE SUPPORT formulations contain the highest strength and potency of Citrus Bergamot SuperFruit, which is the only bergamot extract approved by the prestigious Academia Del Bergamotto in Calabria, Italia. It is a true superfruit backed by clinical data available here.
Whitney’s new products address the fast-growing market for natural health supplements. The brain health supplements market that is projected to grow at an 8% CAGR to reach $13.4 billion by 2028. The sports and fitness nutrition market is expected to reach $34.5 billion by 2028, expanding at a CAGR of 10.9%.
“I’m looking forward to working with Healthy Extracts on additional formulations centered around gut health, hormone health and mental health,” stated Whitney. “These are all areas that I’m super passionate about in my coaching and own daily habits.”
To learn more about Whitney Johns’ product line visit whitneyjohns.com/nutrition today. To learn more about Whitney, visit @whitneyjohns Linktree here.
To learn more about the Healthy Extracts influencer program, call +1 (720) 463-1004 or email info@healthyextractsinc.com.
About Healthy Extracts “Live Life Young Again”
Healthy Extracts Inc. is a platform for developing or acquiring science-forward, clinically proven, plant-based proprietary products in select high-growth categories within the multibillion-dollar nutraceuticals market.
The company’s subsidiaries, BergametNA™ and Ultimate Brain Nutrients™ (UBN), offer nutraceutical natural heart and brain health supplements. This includes the only heart health supplement containing Citrus Bergamot SuperFruit™. This superfruit is known to have the highest quality and concentration of polyphenols and flavonoids, and with healthy heart benefits backed by more than 17 clinical studies.
UBN KETONOMICS® proprietary formulations have been clinically shown to improve brain health, including memory, cognition, focus and neuro-energy. UBN is pursuing intellectual property license opportunities for monetizing its IP portfolio of multiple issued and pending patents.
For more information visit: healthyextractsinc.com, bergametna.com or tryubn.com.
Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Annual Report on Form 10-K filed with the SEC on February 19, 2021, and future periodic reports filed with the SEC. All of the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.
The Company cautions that statements and assumptions made in this news release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.
Food and Drug Administration Disclosure
The product and formulation featured in this release is not for use by or sale to persons under the age of 12. This product should be used only as directed on the label. Consult with a physician before use if you have a serious medical condition or use prescription medications. A doctor’s advice should be sought before using this and any supplemental dietary product. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.
BergametNA™, Ultimate Brain Nutrients™, UBN™, Citrus Bergamot SuperFruit™ and F4T® are registered trademarks of Healthy Extracts Inc.™
Healthy Extracts Company Contact
Duke Pitts, President
Healthy Extracts Inc.
Tel (720) 463-1004
Email contact
Investor & Media Contact
Ronald Both or Justin Lumley
CMA Investor & Media Relations
Tel (949) 432-7566
Email contact
Four photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/46a8f070-0dce-4ec2-8646-976bea2bc719
https://www.globenewswire.com/NewsRoom/AttachmentNg/85be5faa-b0ba-416e-941f-130e1eaf8de4
https://www.globenewswire.com/NewsRoom/AttachmentNg/bf0b3dc8-2bc8-4f4c-8d4f-168c7392ec43
https://www.globenewswire.com/NewsRoom/AttachmentNg/621b2c4d-9d0c-4556-96cb-06884fba4926

(Bloomberg) — Sinovac Biotech Ltd.’s coronavirus vaccine, one of the most widely used in the world, does not provide sufficient antibodies to neutralize the omicron variant, according to a Hong Kong study of 25 individuals. The World Health Organization is concerned omicron is being dismissed as mild, even as it spreads faster than any previous Covid-19 strain. Most Read from BloombergZero Taxes, Golf and Beach Houses Create a Crypto Island ParadiseCan Indoor Farms Reach Skyscraper Height?China
Antiviral drug Paxlovid stayed 89% effective at reducing the risk of hospitalization and death in a final analysis of a key study in high-risk adults.
Is Pfizer stock a buy after a new Covid variant emerged that partially eludes protection from its Covid shot? Is PFE stock a buy right now?
Aurinia Pharmaceuticals (AUPH) has been in the news for a couple of reasons over the past few weeks. First there were rumors the biotech was a bolt on accusation target for Novartis, marking another instance of a pharma giant showing interest in Aurinia. Then, the company released positive topline results from the AURORA 2 continuation study. This is an investigation of the long-term safety and tolerability of Lupkynis (voclosporin), Aurinia’s treatment for adults with active lupus nephritis (LN
A new private study by South Africa’s Discovery Health suggests that Pfizer Inc (NYSE: PFE) and BioNTech SE’s (NASDAQ: BNTX) COVID-19 vaccine is just 33% effective against infections by the omicron variant. However, the Company reported that the variant appears to cause less severe disease. Based on 211,000 positive COVID-19 cases, the data showed that the risk of hospitalization was 29% lower than in South Africa’s first wave back in mid-2020. The Pfizer/BioNTech shot was 70% effective at preve
How can people best be inoculated against the anti-vaccination propaganda spewed daily, Tom Elias writes?
All three U.S.-authorized COVID-19 vaccines appear to be significantly less protective against the newly-detected Omicron variant of the coronavirus in laboratory testing, but a booster dose likely restores most of the protection, according to a study released on Tuesday. The study from researchers at Massachusetts General Hospital (MGH), Harvard and MIT that has not yet been peer reviewed tested blood from people who received the Moderna, Johnson & Johnson and Pfizer/BioNTech vaccines against a pseudovirus engineered to resemble the Omicron variant. The researchers found "low to absent" antibody neutralization of the variant from the regular regimens of all three vaccines – two shots of the Moderna or Pfizer/BioNTech vaccines or one of J&J's single-dose vaccine.
Dr Angelique Coetzee first raised the alarm about the variant almost four weeks ago.
Is Merck stock a buy or sell after its Covid pill, molnupiravir, passed muster with FDA advisors? Is MRK stock a buy or sell right now?
Multiple reports show insulin prices continue to surge because of a rebate system that leaves diabetics footing the bill and middlemen and insurers cashing in.
Pfizer Inc. said Monday it has agreed to acquire Arena Pharmaceuticals Inc. in a deal with a value of about $6.7 billion, sending Pfizer shares to their highest close ever, and Arena shares to their largest one-day gain.
The decision is the latest sign that the emergence of Omicron and rising case counts in some parts of the country are complicating a return to normalcy.
A Bucks County biopharmaceutical company working on a cure for chronic hepatitis B has entered into a licensing and partnership deal with a Chinese pharmaceutical firm valued at up to $300 million. Under the terms of the agreement, Qilu Pharmaceutical of Jinan will get exclusive rights to AB-729, Arbutus Biopharma's lead new drug candidate for the treatment or prevention of hepatitis B, in mainland China, Hong Kong, Macau and Taiwan. In return, Arbutus (NASDAQ: ABUS) of Warminster will receive $40 million in an upfront payment, up to $245 million in development and commercialization milestone payments, double-digit tiered royalties, and a $15 million equity investment. William Collier, CEO of Arbutus, called Qilu an "ideal partner" because of the company's extensive development, regulatory and commercialization capabilities in China.
Baby Oaklynn Koon died after she and her family were ripped from the bathroom they were hiding in and flung out onto the street by a powerful tornado
Keith Smith, who had been on a ventilator, received two doses of the controversial drug before his condition worsened. He died Sunday at age 52.
Tuesday marks one year since COVID-19 vaccinations became available in the United States to those who qualified for them.
(Bloomberg) — New study data showed Pfizer Inc.’s experimental Covid-19 pill was highly effective at keeping patients out of the hospital but less adept at erasing milder symptoms often associated with breakthrough infections.Most Read from BloombergZero Taxes, Golf and Beach Houses Create a Crypto Island ParadiseCan Indoor Farms Reach Skyscraper Height?China Is Building the World’s Largest National Park SystemBoris Johnson’s Furious MPs Worry That His Next Misstep Could Be FatalThe omicron var
According to the World Health Organization (WHO), cardiovascular disease (CVD) is the leading cause of death in America and around the world. In fact, in the United States, CVD claims another life every 36 seconds, accounting for one in every four deaths in the nation. However, the American Heart Association (AHA) points out that roughly 80 percent of cardiovascular disease is believed to be preventable, using simple interventions such as eating a healthier diet and getting more exercise.And bas
Adding this unique healthcare conglomerate to your portfolio now could lead to heaps of dividend income down the road.
Local cases of the Omicron variant of Covid officially doubled today, as Los Angeles County announced eight additional infections of the virus mutation, while Pasadena health officials verified that city’s first case. The new cases confirmed by the county Department of Public Health brought the number of Omicron cases in that agency’s jurisdiction to 15. […]

source